Is There a Need for Cholesteryl Ester Transfer Protein Inhibition?-Reference-Cited by-同舟云学术

Is There a Need for Cholesteryl Ester Transfer Protein Inhibition?

Published:2003-03 Issue:3 Volume:23 Page:374-375
ISSN:1079-5642
Container-title:Arteriosclerosis, Thrombosis, and Vascular Biology
language:en
Short-container-title:ATVB

Author:

Parini Paolo¹,Rudel Lawrence L.¹

Affiliation:

1. From the Metabolism Unit (P.P.), Center for Metabolism and Endocrinology, Department of Medicine, Karolinska Institute at Huddinge University Hospital, Huddinge, Sweden, and Arteriosclerosis Research Program (L.L.R.), Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, NC.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/01.ATV.0000060447.25136.1C

Reference12 articles.

1. Serum Lipoproteins and Coronary Heart Disease in a Population Study of Hawaii Japanese Men

2. Cholesteryl Ester Transfer Protein

3. Unraveling the mysteries of high density lipoprotein metabolism

4. Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HDL, reverse cholesterol transport, and atherosclerosis: Unravelling the complexity or adding to the confusion?;Atherosclerosis;2024-10

2. High Density Lipoproteins: Metabolism, Function, and Therapeutic Potential;Frontiers in Cardiovascular Medicine;2020-03-31

3. Metabolismus und Funktion der Lipoproteine hoher Dichte (HDL);Praxis;2019-05

4. Navigating the Future of Cardiovascular Drug Development—Leveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference;Cardiovascular Drugs and Therapy;2017-07-22

5. Advances in Hypercholesterolemia;Comprehensive Medicinal Chemistry III;2017